Condition
Primary Cancer
Total Trials
3
Recruiting
2
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (2)
Trial Status
Recruiting2
Active Not Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07011862Not ApplicableActive Not RecruitingPrimary
COBRA: Cancer, Older Adults, Balance and Resistance Activities
NCT06643884Phase 2Recruiting
Suprachoroidal Administration in Subjects With Metastases to the Choroid
NCT05855811Phase 2Recruiting
PREventing Second Cancers With DOSTARlimab
Showing all 3 trials